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Abstract

Author Manuscript

Objective—Anxiety and depression can substantially impact the life of a cancer patient, but
literature on emotional distress in the Hispanic cancer population is sparse. Additionally, the
influence of psychosocial variables including age, acculturation, and spiritual wellbeing on
emotional distress in this population remains unclear. The purpose of the present report was to
assess the prevalence of anxiety and depression in Spanish-speaking Latina cancer patients
preparing to begin chemotherapy and to explore the predictors and correlates of these outcomes.
Methods—Participants were 198 Spanish-speaking Latina cancer patients who completed
measures of anxiety, depression, acculturation, and spiritual wellbeing prior to starting
chemotherapy.

Author Manuscript

Results—Prevalence of clinically significant anxious symptomatology was 52%, and prevalence
of clinically significant depressive symptomatology was 27%. Longer time since diagnosis and
less acculturation predicted more severe anxiety, while longer time since diagnosis, less
acculturation, and older age predicted more severe depression (ps < .05). In multivariable analyses,
only time since diagnosis emerged as a significant predictor of anxiety and depression when
accounting for the influence of other variables. Greater spiritual wellbeing was correlated with
both less severe anxiety and less severe depression (ps < .001).
Conclusions—The present findings document the high prevalence of emotional distress,
particularly anxiety, in this patient population prior to chemotherapy initiation and identify several
demographic and clinical factors associated with increased risk for heightened distress.
Additionally, these findings suggest that interventions to address distress in this patient population
would benefit from including components that seek to improve patients’ spiritual wellbeing.
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Cancer diagnosis and treatment is a life-altering experience that can be accompanied by an
increased risk of experiencing symptoms of anxiety and depression. (Linden,Vodermaier,
MacKenzie, & Greig, 2012). Although much is known about anxiety and depression among
cancer patients in general, research focused on the Hispanic cancer population has been
sparse. Comprising 16% of the U.S. population, Hispanics are the largest ethnic minority
group in the U.S. (U.S. Census, 2010). This study explored the prevalence, predictors, and
correlates of anxiety and depression symptoms in Spanish-speaking Latina cancer patients
preparing to undergo chemotherapy.
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Emotional distress in the form of anxiety and/or depression can have a substantial impact on
the quality of life of cancer patients and has been referred to as the sixth vital sign in cancer
care (Bultz & Carlson, 2005). Although prevalence estimates vary widely from study to
study (e.g., see reviews by Mitchell et al., 2011 and Van’t Spijker, Trijsburg, &
Duivenvoorden, 1997), a recent study of over 10,000 cancer patients found that
approximately 32% experienced at least subclinical symptoms of anxiety in the postdiagnosis period; the prevalence of at least subclinical depression was slightly lower at
approximately 29% (Linden et al., 2012). Estimates of depression prevalence in the Latina
cancer population likewise vary greatly, with estimates ranging from just over 10% to nearly
25% for major depressive disorder (Costas & Gany, 2013; Ell et al., 2005) and from 32% to
53% for clinically significant depression symptoms (Ashing-Giwa, Rosales, Lai, & Weitzel,
2013; Holden, Ramirez, & Gallion, 2014). Anxiety symptoms have received much less
attention in the Latina cancer patient population; anxiety prevalence in this population
remains relatively unexplored.
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Age may play a role in cancer patients’ psychological well-being. Many studies suggest that
age is inversely related to emotional distress in the overall cancer population, with younger
patients experiencing more distress (Mosher & Danoff-Burg, 2006; Van’t Spijker et al.,
1997), but some fail to find a relationship between age and emotional distress (e.g., Rabin,
Leventhal, & Goodin, 2004). Findings specific to the Latina cancer population are similarly
mixed. For example, one study of a mixed cancers sample of Latinas found that women
between 50 and 64 reported greater severity of depression symptoms compared to women
aged 65 and older, while symptoms were less severe in the youngest women (<50 years old)
compared to the 65 and older women (Ashing-Giwa et al., 2013). However, another study of
Latina breast cancer survivors found no effect of age on depression symptoms (Aguado Loi
et al., 2013).
Acculturation, often defined as “acquisition of the cultural elements of the dominant
society” (Lara, Gamboa, Kahramanian, Morales, & Bautista, 2005), may influence a Latina
cancer patient’s treatment experience. Latina patients being treated for cancer in the U.S.
bring their own cultural values and customs. Additionally, for many Latinas, English is not
Psychooncology. Author manuscript; available in PMC 2019 January 01.
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their primary language, and they may prefer to communicate and receive information in
Spanish (Huerta & Macario, 1999; Kar, Alcalay, & Alex, 2001). The cancer treatment
process is often demanding in terms of language, literacy, and fluency (IOM, 1999; IOM,
2004), and the dominant culture’s approach may not align with a Latina patient’s culturallyinformed preferences.
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Many studies have explored the relationship between acculturation and distress in the
general population. Some studies find that reports of depression decrease as acculturation
increases (e.g., Torres & Rollock, 2007; Gonzalez, Haan, & Hinton, 2001), others find that
depression is greater as acculturation increases (e.g., Ramos, 2005; Rivera, 2007), and some
find no relationship between acculturation and depression (e.g., Capielo, Delgado-Romero,
& Stewart, 2015; Masten et al., 2004; Torres, 2010). The relationship between acculturation
and distress specifically in the Latina cancer population does not appear to have been
evaluated formally in the literature to-date.
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Finally, the extent to which cancer patients experience distress can be influenced by spiritual
wellbeing, which may act as a coping resource. Spiritual wellbeing may be particularly
salient for Latinas, who report using more religious coping strategies than non-Hispanic
white women (Culver, Arena, Antoni, & Carver, 2002; Culver, Arena, Wimberly, Antoni, &
Carver, 2004). Spiritual wellbeing can be conceptualized as a combination of meaning,
peace, and purpose on the one hand and faith and spiritual beliefs on the other (Peterman,
Fitchett, Brady, Hernandez, & Cella, 2002). Higher levels of spirituality have been
associated with lower levels of depression in cancer patients (McClain, Rosenfeld, &
Breitbart, 2003; Nelson, Rosenfeld, Breibart, & Galietta, 2002), and some literature suggests
that the meaning/peace aspect of spiritual wellbeing is more influential than the faith aspect
(Bai & Lazenby, 2015; Nelson et al., 2002).
The purpose of the present report was to assess the prevalence of anxiety and depression in
Spanish-speaking Latina cancer patients preparing to begin chemotherapy using a validated
Spanish-language measure and to explore the predictors and correlates of these outcomes. In
light of the mixed findings in the existing literature, hypotheses were not formulated for the
relationships of age and acculturation with distress. However, spiritual well-being,
particularly the meaning/peace aspect, was expected to be associated with lower levels of
anxiety and depression.

Method
Participants and Procedure

Author Manuscript

Participants included in the current analyses were recruited between April 2012 and
November 2015 as part of a larger institutional review board-approved stress management
intervention study (University of South Florida IRB# Pro00006699, University of Miami
IRB #20111145). The study’s eligibility criteria required all participants to (1) be at least 18
years of age, (2) be female, (3) self-identify as Hispanic or Latina, (4) be able to speak and
read Spanish, (5) be diagnosed with cancer and scheduled to start outpatient intravenous
chemotherapy for reasons other than symptom palliation, (6) have not received
chemotherapy in the past two months, (7) have no documented or clearly observable
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disorders that would impede participation in the study (e.g., blindness or psychosis), and (8)
be willing to provide written informed consent. Potential participants were identified via
electronic appointment systems at Moffitt Cancer Center, the University of Miami/Sylvester
Comprehensive Cancer Center, and Jackson Memorial Hospital. They were recruited by
trained research associates in person during their initial consultations with attending
oncologists or just prior to their first chemotherapy infusion. In the larger study from which
this sample was drawn, 91% of patients who were approached agreed to participate. Patients
who met eligibility criteria and provided informed consent completed a packet of Spanishlanguage questionnaires in a private area of the clinic. Data for the present analyses came
from this pre-chemotherapy (baseline) assessment that was conducted before participants
were notified of their intervention assignment in the larger study.
Measures

Author Manuscript

Patient characteristics—Patients’ demographic characteristics were collected using a
standard self-report questionnaire. Clinical characteristics were obtained through medical
chart review.
Acculturation—Acculturation was assessed using the Short Acculturation Scale for
Hispanics (SASH), which evaluates acculturation with respect to preference for Spanish
versus English in the contexts of language use, media, and ethnic social relations (Marin,
Sabogal, Marin, Otero-Sabogal, & Perez-Stable, 1987). The SASH contains 12 items rated
on a 5-point scale, with higher scores indicating a greater degree of acculturation. In the
present study, Cronbach’s alpha for the SASH was .94.

Author Manuscript

Anxiety and depression—Symptoms of anxiety and depression were assessed using the
validated Spanish version of the Hospital Anxiety and Depression Scale (HADS), which
contains 14 items that assess frequency of experiencing symptoms of anxiety (7 items) and
depression (7 items) in the past week on 4-point scale. Scores for each subscale range from
0–21, with higher scores indicating greater symptomatology (Herrero et al., 2003; Zigmond
& Snaith, 1983). In the present study, Cronbach’s alpha was .84 for anxious
symptomatology and .82 for depressive symptomatology. Analyses for clinically significant
anxiety and depression were conducted using the cutoffs of 8 for anxiety and 8 for
depression as is generally recommended (Bjelland, Dahl, Tangen Haug, & Neckelmann,
2002).

Author Manuscript

Spiritual wellbeing—Spiritual wellbeing was assessed using the validated Spanish
version of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale
(FACIT-Sp) (Peterman et al., 2002). The FACIT-Sp contains 12 items rated on a 5-point
scale and yields scores for meaning/peace and faith, with higher scores indicating greater
wellbeing. In the present study, Cronbach’s alpha was .85 for meaning/peace and .89 for
faith.
Statistical Analyses
Before testing study hypotheses, means and frequencies were computed for participant
demographic and clinical characteristics as well as anxious and depressive symptomatology.
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Next, independent relationships between outcomes (anxious and depressive
symptomatology) and potential predictors (participant demographic and clinical
characteristics, years in U.S., and acculturation) and correlates (spiritual well-being) were
evaluated in correlational analyses. Finally, separate regression analyses were conducted for
anxious and depressive symptomatology in which demographic characteristics (age, race,
marital status, and education) years in U.S., acculturation, and clinical characteristics (time
since diagnosis and cancer stage) were entered simultaneously.

Results
Participant Characteristics

Author Manuscript

The present analyses include data from 198 Spanish-speaking Latina cancer patients.
Demographic, clinical, and psychosocial characteristics of the sample are presented in Table
1. The wide range in days from diagnosis to study participation partly reflects the fact that
16 women were undergoing treatment for recurrent cancer.
Prevalence of Anxiety and Depression
Participants’ mean score on the anxiety subscale of the HADS was 7.92 (SD = 4.36; range =
0–21), and 52% met the cutoff for clinically significant anxious symptomatology.
Participants’ mean score on the depression subscale of the HADS was 4.80 (SD = 4.02;
range = 0–17), and 27% met the cutoff for clinically significant depressive symptomatology.
Just under one-fourth of participants (23%) met the cutoff for clinical significance for both
anxiety and depression, 29% met the cutoff for anxiety only, 4% met the cutoff for
depression only, and 44% did not meet either cutoff.

Author Manuscript

Predictors of Anxiety and Depression
Correlations between potential predictors of distress and anxious and depressive
symptomatology are presented in Table 1. Only time since diagnosis and acculturation were
significantly correlated with anxiety, such that more time since diagnosis and a lower degree
of acculturation were associated with greater anxious symptomatology. Acculturation’s
relationship with anxiety was driven primarily by the media subscale (r = −.17, p = .01); the
other two subscales did not correlate significantly with anxiety (r = −.13, p = .08 for the
language subscale and r = −.10, p = .16 for the social subscale). The same was true for the
relationship between acculturation and depression (media subscale: r = −.15, p = .03;
language subscale: r = −.13, p = .06; social subscale: r = −.12, p = .10). Time since diagnosis
and age were significantly correlated with depression such that more time since diagnosis
and older age were associated with greater depressive symptomatology.

Author Manuscript

Correlates of Anxiety and Depression
Greater spiritual wellbeing was associated with lower anxiety (r = −.53, p < .001) and
depression scores (r = −.62, p < .001). These relationships were stronger for the meaning/
peace subscale (anxiety: r = −.60, p < .001; depression: r = −.65, p < .001) than for the faith
subscale (anxiety: r = −.23, p = .001; depression: r = −.36, p < .001).
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Results of regression analyses predicting anxiety and depression scores from demographic
characteristics (age, race, marital status, and education), years in U.S., acculturation, and
clinical characteristics (time since diagnosis and cancer stage) are presented in Table 2.
Together the variables predicted 8% of the variance in anxiety, and only time since diagnosis
emerged as a significant predictor when accounting for the influence of the other variables
(β = .21, p = .01). Similarly, the variables predicted 9% of the variance in depression, and
only time since diagnosis was a significant predictor (β = .22, p = .01).

Discussion

Author Manuscript

In the present sample of Latina cancer patients preparing to begin chemotherapy, both
anxiety and depression were highly prevalent, with 52% of patients reporting clinically
significant levels of anxious symptomatology and 27% of patients reporting clinically
significant levels of depressive symptomatology. Longer time since diagnosis and a lower
degree of acculturation were associated with greater anxious and depressive
symptomatology, and older age was associated with greater depressive symptomatology.
Spiritual wellbeing, particularly the meaning/peace aspect, was related to both anxiety and
depression such that greater spiritual wellbeing was associated with less emotional distress.
Accounting for the influence of other variables, only time since diagnosis was a significant
predictor of anxiety and depression in multivariable analyses.

Author Manuscript

The prevalence of clinically significant depressive symptomatology observed in this study
(27%) using the HADS is comparable to that observed in a recent study of Latina breast
cancer survivors using the standard English version of the Center for Epidemiologic Studies
Depression Scale (32%) (Holden et al., 2014). The prevalence of clinically significant
anxious symptomatology (52%) was much higher than that observed for depressive
symptomatology. The possibility that anxiety is more common than depression in Latina
cancer patients warrants additional study and underscores the importance of assessing both
symptoms in this population.

Author Manuscript

The positive relationship between age and depressive symptomatology and the lack of a
relationship between age and anxious symptomatology in the present study, while somewhat
unexpected, is not entirely novel. Although studies not limited to Latinas have generally
observed that younger women with cancer experience greater depressive and anxious
symptomatology (Mosher & Danoff-Burg, 2006), findings in the Latina cancer population
have been inconclusive (Aguado Loi et al., 2013; Ashing-Giwa et al., 2013). The present
results indicating that the relationship between age and depression in the Latina cancer
population is opposite to the typical pattern suggest there may be important differences in
how younger and older Latinas are affected emotionally by cancer relative to the general
population. One possible explanation that should be considered for the observed positive
relationship between age and depression is whether older Latinas have a more fatalistic view
of cancer (i.e., a stronger belief that death inevitable when cancer is present) (Powe &
Finnie, 2003).
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The negative relationship observed between acculturation and emotional distress in the
present study should be interpreted in the context of the broader literature where a negative
relationship (e.g., Torres & Rollock, 2007; Gonzalez, Haan, & Hinton, 2001), a positive
relationship (e.g., Ramos, 2005; Rivera, 2007), or no relationship (e.g., Capielo, DelgadoRomero, & Stewart, 2015; Masten et al., 2004; Torres, 2010) have been observed between
these variables in the Hispanic population. The lack of consistent findings seems to be
attributable, in part, to differences across studies in how acculturation has been measured.
Measures of acculturation focus on everything from sociodemographic characteristics and
cultural values to language preferences and preferred groups for social interactions (Marin et
al., 1987). Results from the present study suggest that the presence of items capturing media
language preferences contributed strongly to the observed relationship between acculturation
and emotional distress. Future research should systematically explore how various facets of
acculturation are differentially related to outcomes including emotional distress.

Author Manuscript
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A key finding that emerged from both the univariate and multivariable analyses was the
positive relationship observed between time since diagnosis and emotional distress. It should
be noted that, while the average time since diagnosis was just under four months, the elapsed
time since diagnosis ranged from less than a year to nearly 12 years across patients. One
possible explanation for the observed relationship between time since diagnosis and distress
is that greater elapsed time since diagnosis may be associated with greater likelihood that the
patient is starting chemotherapy for a disease recurrence or progression. Studies using
retrospective data suggest that cancer patients consider news of their recurrence to be more
upsetting than their initial diagnosis (e.g., Mahon, Cella, & Donovan, 1990). In one of the
few controlled studies on this topic, Andersen et al. (2005) found that women assessed
shortly after a breast cancer recurrence reported greater cancer-specific distress than diseasefree women who were matched on time since initial diagnosis. Lack of data in the present
study on disease progression or recurrence precludes a formal evaluation of this possibility.
Study findings provided strong support for the hypothesis that greater spiritual wellbeing
would be associate with less anxiety and depression. These findings are consistent with the
broader literature demonstrating a negative relationship between spiritual wellbeing and
depression in people with cancer (McClain, Rosenfeld, & Breitbart, 2003; Nelson,
Rosenfeld, Breitbart, & Galietta, 2002) and the fact that Latinas with cancer have been found
to rely particularly heavily on religious coping strategies (Culver, Arena, Antoni, & Carver,
2002; Culver, Arena, Wimberly, Antoni, & Carver, 2004). Consistent with prior research
(Bai & Lazenby, 2015; Nelson et al, 2009), correlations with anxiety and depression were
strongest for items measuring the meaning/peace aspect of spiritual well-being.

Author Manuscript

Strengths and Limitations
The current study has several strengths including recruitment of a sample comprised entirely
of Spanish-speaking Latinas with cancer, the multi-site nature of the study, and the
assessment of participants at a key time point in their treatment trajectory (i.e., just prior to
chemotherapy initiation). However, there are also limitations that must be acknowledged.
Study limitations include use of baseline data from individuals who consented to participate
in a study of stress management training (a feature that may limit generalizability), lack of

Psychooncology. Author manuscript; available in PMC 2019 January 01.

Lee et al.

Page 8

Author Manuscript

procedures for diagnosing the presence of actual anxiety and mood disorders rather than
clinically significant symptomatology, and measurement at a single time point that may not
represent these women’s symptoms at all points in the cancer care continuum. Additionally,
the absence of a comparison group precludes comparisons between Latinas and women from
other ethnic backgrounds.
Clinical Implications

Author Manuscript

Nevertheless, the study yielded several findings with implications for clinical practice. First,
results showing that clinically significant emotional distress is common prior to
chemotherapy initiation reinforces the importance of routinely screening for and addressing
anxiety and depression in this patient population at this pivotal time, as recommended by
clinical practice guidelines (Andersen et al, 2015). Furthermore, these services should to be
made available in the patient’s preferred language. Second, the present results identify
several factors that may help to identify Latinas at particular risk for heightened distress
prior to chemotherapy initiation (i.e., those who are older, less acculturated, and longer from
the time of diagnosis). Third, findings regarding spiritual wellbeing suggest that
interventions to address heightened distress in this patient population may be particularly
beneficial if they include components focused on finding meaning in and accepting one’s
current life situation, strategies common to several positive psychology and “third wave”
intervention approaches (Casellas-Grau et al, 2014; Hulbert-Williams et al, 2015).
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Table 1

Author Manuscript

Participants’ demographic, clinical, and psychosocial characteristics (N = 198)
Variable

Mean

SD

Age (years)

51.77

13.87

27–87

114

339

2–4316

Years in U.S.

24.76

17.05

0–64

SASH score

25.15

10.75

12–52

FACIT-Sp score

38.63

7.56

15–48

N

% of valid cases

Race (White)

146

84.4

Marital status (married)

104

52.8

Education (high school graduate)

104

66.5

U.S. and territories

45

24.9

Mexico

16

8.8

Central America

19

10.5

South America

26

14.4

Caribbean

75

41.4

Breast

160

80.8

Ovarian

12

6.1

Other

26

13.1

Stage 1

32

16.2

Stage 2

83

41.9

Stage 3

67

33.8

Stage 4

16

8.1

Days since diagnosis

Variable

Range

Author Manuscript

Place of Origin

Cancer Type

Cancer Stage

Author Manuscript
Author Manuscript

Psychooncology. Author manuscript; available in PMC 2019 January 01.

Author Manuscript

Author Manuscript

Author Manuscript
−.07

.20**

Depression

p < .001.

***

p < .01,

**

p < .05,

*

Note.

.04

.03

Race

Anxiety

Age

−.13

.00

Marital Status

−.09

−.12

Education

−.13

−.13

−.15*
−.15*

SASH Lang.

SASH Total

−.15*

−.17*

SASH Media

−.12

−.10

SASH Social

Correlations between potential predictors of distress and anxious and depressive symptomatology.

−.01

−.07

Years in U.S.

.08

.04

Disease Stage

.17*

.17*

Time Since DX

Author Manuscript
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Author Manuscript

Regression analyses predicting anxious and depressive symptomatology.

Author Manuscript

Beta

P-value

.00

.97

Race

.06

.43

Marital Status

−.03

.66

Education

−.05

.55

Years in U.S.

.03

.81

Acculturation

−.15

.19

Time Since Diagnosis

.21

.01

Stage

.03

.74

Age

.12

.21

Race

−.02

.84

Marital Status

−.12

.13

Education

.00

.96

Years in U.S.

.03

.81

Acculturation

−.12

.31

Time Since Diagnosis

.22

.01

Stage

−.02

.80

Anxiety
Age

Depression

Note. Anxiety: F(8,152) = 1.55, p = .14. Depression: F(8,152) = 1.93, p = .06.
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